Lot A. Devriese

Department Of Head And Neck Surgical Oncology, Heidelberglaan 100
Utrecht, UT 3584CX, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

The Prognostic Effect of Sarcopenia in Solid Cancers Treated with Immunotherapy: A Systematic Review and Meta-Analysis.

The Prognostic Effect of Sarcopenia in Solid Cancers Treated with Immunotherapy: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical medicine

Published: February 14, 2026

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

Journal: The Annals of otology, rhinology, and laryngology

Published: January 18, 2026

Real-world effectiveness of molecular-matched therapies in salivary gland cancer.

Real-world effectiveness of molecular-matched therapies in salivary gland cancer.

Journal: ESMO open

Published: January 08, 2026

Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma.

Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma.

Journal: EMBO molecular medicine

Published: January 06, 2026

Prognostic Impact of Tumor Stage and Growth Pattern in Sinonasal Adenoid Cystic Carcinoma: A 15-Year Population-Based Study.

Prognostic Impact of Tumor Stage and Growth Pattern in Sinonasal Adenoid Cystic Carcinoma: A 15-Year Population-Based Study.

Journal: Head & neck

Published: November 21, 2025

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Journal: Journal for immunotherapy of cancer

Published: August 22, 2025

Head and Neck Cancer in Suriname: An Epidemiologic Review of Clinical and Pathologic Features of Patients Treated Between 2009 and 2021.

Head and Neck Cancer in Suriname: An Epidemiologic Review of Clinical and Pathologic Features of Patients Treated Between 2009 and 2021.

Journal: JCO global oncology

Published: August 06, 2025

International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies.

International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies.

Journal: Journal of the National Cancer Institute

Published: August 04, 2025

Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment.

Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment.

Journal: Pharmaceutics

Published: July 18, 2025

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Journal: British journal of cancer

Published: June 13, 2025

Long-term survival after multimodal treatment of sinonasal NUT carcinoma: a case report.

Long-term survival after multimodal treatment of sinonasal NUT carcinoma: a case report.

Journal: Oral oncology

Published: May 22, 2025

[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 06, 2025

Showing 1-12 of 69

Last Updated: 09/26/2026